Literature DB >> 6970173

Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets.

J Van Wauwe, J Goossens.   

Abstract

The complement-mediated lysis of human lymphocytes by three monoclonal anti-human T-cell antibodies OKT3.PAN, OKT4.INd and OKT8.SUP was studied. The percentages of Ficoll-Hypaque-isolated mononuclear cells lysed by these antibodies were respectively: 65% for OKT3.PAN, 39% for OKT4.IND and 20% for OKT8.SUP. Optimal lymphocytotoxic reactions were noticed when unabsorbed rabbit serum was used as the source of complement (C). Addition of heat-inactivated human, mouse and newborn calf sera but not of foetal calf serum inhibited the lytic activity of the antibodies. Treatment of peripheral mononuclear blood cells with OKT3.PAN and C abrogated their mitotic response to PHA and Con-A. Sheep erythrocyte rosetting lymphocytes (E+ cells) treated with OKT4.IND or OKT8.SUP and C exhibited no marked changes in responsiveness to PHA, Con-A or allogeneic non-T cells. However, only E+ cells enriched with OKT4.IND-reactive cells responded to purified protein derivative, proliferated in the autologous mixed lymphocyte reaction and were highly sensitive to hydrocortisone suppression when stimulated by PHA. Our data indicate that these monoclonal antibodies can be regarded as invaluable tools for enumeration, characterization and functional assessment of human T cells and their subclasses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970173      PMCID: PMC1458216     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.

Authors:  J Brochier; Y A Abou-Hamed; J P Gueho; J P Revillard
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

2.  Studies on the human T-lymphocyte population. I. The development and characterization of a specific anti-human T-cell antibody.

Authors:  F L Owen; M W Fanger
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  Identification and quantitation of thymus-derived lymphocytes in human peripheral blood.

Authors:  A M Bobrove; S Strober; L A Herzenberg; J D DePamphilis
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  An antigen density effect on the hemolytic efficiency of complement.

Authors:  W D Linscott
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

5.  Suppression of the human autologous mixed lymphocyte reaction by physiologic concentrations of hydrocortisone.

Authors:  D N Ilfeld; R S Krakauer; R M Blaese
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

6.  Inhibition of natural cytotoxic rabbit antibody by human IgM: production of nontoxic rabbit serum for use as complement source.

Authors:  R B Herberman
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

7.  Function and distribution pattern of human T lymphocytes. II. Presence of T lymphocytes in normal humans and in humans with various immunodeficiency disorders.

Authors:  F Aiuti; H Wigzell
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

8.  Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses.

Authors:  H Cantor; F W Shen; E A Boyse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens.

Authors:  R L Evans; J M Breard; H Lazarus; S F Schlossman; L Chess
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  9 in total

1.  Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.

Authors:  K Kalli; C Huntoon; M Bell; D J McKean
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Application of the biotin-avidin system for ultrastructural identification of suppressor/cytotoxic lymphocytes in oral lichen planus.

Authors:  T Löning; D Schmitt; W M Becker; J Weiss; M Jänner
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

3.  T cell and T cell subset determination in normal peripheral blood: comparison of the indirect immunofluorescence and lymphocytotoxicity techniques.

Authors:  R Patel; C Williams; D R Patel
Journal:  Experientia       Date:  1984-12-15

4.  Radiosensitivity of isolated subsets of human lymphocytes (E+, OKT4+, OKT8+): protective role of monocytes and monokines.

Authors:  I Manori; A Kushilevsky; S Segal; Y Weinstein
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

5.  Local T cell subsets in mumps meningitis.

Authors:  H Nagai; T Morishima; Y Morishima; S Isomura; S Suzuki
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

6.  Deficient autologous mixed lymphocyte reaction in Kaposi's sarcoma associated with deficiency of Leu-3+ responder T cells.

Authors:  S Gupta; B Safai
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A.

Authors:  J Van Wauwe; J Goossens; W Decock; P Kung; G Goldstein
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

8.  A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection.

Authors:  J H Joncas; F Ghibu; M Blagdon; S Montplaisir; I Stefanescu; J Menezes
Journal:  Can Med Assoc J       Date:  1984-02-01       Impact factor: 8.262

9.  T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.

Authors:  D R McCluskey; A D Roy; W P Abram; W M Martin
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.